Literature DB >> 12893846

A natural product ligand of the oxysterol receptor, liver X receptor.

Kelli S Bramlett1, Keith A Houck, Kristen M Borchert, Michele S Dowless, Palaniappan Kulanthaivel, Youyan Zhang, Thomas P Beyer, Robert Schmidt, Jeffrey S Thomas, Laura F Michael, Robert Barr, Chahrzad Montrose, Patrick I Eacho, Guoqing Cao, Thomas P Burris.   

Abstract

Natural products have been identified as ligands for a number of members of the nuclear hormone receptor (NHR) superfamily. Often these natural products are used as dietary supplements to treat myriad ailments ranging from perimenopausal hot flashes to hypercholesterolemia and reduced cognitive function. Examples of some natural product ligands for NHRs include genestein (estrogen receptors NR3A1 and NR3A2), guggulsterone (farnesoid X receptor NR1H4), and St. John's wort (pregnane X receptor, NR1I2). In this study, we identified the first nonoxysterol natural product that functions as a ligand for the liver X receptor (LXRalpha and LXRbeta; NR1H3, NR1H2), a NHR that acts as the receptor for oxysterols and plays a key role in regulation of cholesterol metabolism and transport as well as glucose metabolism. We show that paxilline, a fungal metabolite, is an efficacious agonist of both LXRalpha and LXRbeta in biochemical and in vitro cell-based assays. Paxilline binds directly to both receptors and is an activator of LXR-dependent transcription in cell-based reporter assays. We also demonstrate that paxilline binding to the receptors results in efficient activation of transcription of two physiological LXR target genes, ABCA1 and SREBP. The discovery of paxilline, the first reported nonoxysterol natural product ligand of the LXRs, may provide insight into the mechanism of ligand recognition by these receptors and reaffirms the utility of examining natural product libraries for identifying novel NHR ligands.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12893846     DOI: 10.1124/jpet.103.052852

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  17 in total

1.  Identification of SR1078, a synthetic agonist for the orphan nuclear receptors RORα and RORγ.

Authors:  Yongjun Wang; Naresh Kumar; Philippe Nuhant; Michael D Cameron; Monica A Istrate; William R Roush; Patrick R Griffin; Thomas P Burris
Journal:  ACS Chem Biol       Date:  2010-11-19       Impact factor: 5.100

Review 2.  Therapeutic interventions to enhance apolipoprotein A-I-mediated cardioprotection.

Authors:  Michael J Haas; Arshag D Mooradian
Journal:  Drugs       Date:  2010-05-07       Impact factor: 9.546

3.  Pomegranate flower improves cardiac lipid metabolism in a diabetic rat model: role of lowering circulating lipids.

Authors:  Tom Hsun-Wei Huang; Gang Peng; Bhavani Prasad Kota; George Qian Li; Johji Yamahara; Basil D Roufogalis; Yuhao Li
Journal:  Br J Pharmacol       Date:  2005-07       Impact factor: 8.739

4.  Coronary heart disease: Significance of liver X receptor α genomics.

Authors:  Vivek Priy Dave; Deepak Kaul
Journal:  World J Cardiol       Date:  2010-06-26

5.  Coupling of receptor conformation and ligand orientation determine graded activity.

Authors:  John B Bruning; Alexander A Parent; German Gil; Min Zhao; Jason Nowak; Margaret C Pace; Carolyn L Smith; Pavel V Afonine; Paul D Adams; John A Katzenellenbogen; Kendall W Nettles
Journal:  Nat Chem Biol       Date:  2010-10-10       Impact factor: 15.040

6.  Liver X receptors contribute to the protective immune response against Mycobacterium tuberculosis in mice.

Authors:  Hannelie Korf; Seppe Vander Beken; Marta Romano; Knut R Steffensen; Benoît Stijlemans; Jan-Ake Gustafsson; Johan Grooten; Kris Huygen
Journal:  J Clin Invest       Date:  2009-05-11       Impact factor: 14.808

7.  Combinations of LXR and RXR agonists induce triglyceride accumulation in human HepaRG cells in a synergistic manner.

Authors:  Alexandra Lasch; Jimmy Alarcan; Alfonso Lampen; Albert Braeuning; Dajana Lichtenstein
Journal:  Arch Toxicol       Date:  2020-03-02       Impact factor: 5.153

8.  Ligand specificity and evolution of liver X receptors.

Authors:  Erica J Reschly; Ni Ai; William J Welsh; Sean Ekins; Lee R Hagey; Matthew D Krasowski
Journal:  J Steroid Biochem Mol Biol       Date:  2008-03-10       Impact factor: 4.292

9.  Lipogenesis in arterial wall and vascular smooth muscular cells: regulation and abnormalities in insulin-resistance.

Authors:  Nadjiba Hamlat; Fabien Forcheron; Samia Negazzi; Peggy del Carmine; Patrick Feugier; Giampiero Bricca; Souhila Aouichat-Bouguerra; Michel Beylot
Journal:  Cardiovasc Diabetol       Date:  2009-12-23       Impact factor: 9.951

10.  Effects of liver X receptor agonist treatment on pulmonary inflammation and host defense.

Authors:  Kathleen Smoak; Jennifer Madenspacher; Samithamby Jeyaseelan; Belinda Williams; Darlene Dixon; Katie R Poch; Jerry A Nick; G Scott Worthen; Michael B Fessler
Journal:  J Immunol       Date:  2008-03-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.